Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience

Breast Cancer Research and Treatment

Volumn 161, Issue 2, 2017, Pages 289-297

  Bourke, Mike G ^a   Salwa, Slav P ^a   Sadadcharam, Mira ^a   Whelan, Maria C ^a   Forde, Patrick F ^a   Larkin, John O ^a   Collins, Chris G ^a   O’Reilly, Seamus ^b   O’Sullivan, Gerald C ^a   Clover, A James ^a,c   Soden, Declan M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b MERCY UNIVERSITY HOSPITAL   (Ireland)

^c SOUTH INFIRMARY VICTORIA UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Bleomycin; Breast cancer; Cutaneous metastases; Electrochemotherapy; Locoregional recurrence

Indexed keywords

BLEOMYCIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RECURRENCE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INFORMED CONSENT; MALE; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PULSE GENERATOR; SIMPLE MASTECTOMY; SKIN METASTASIS; BREAST TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SECONDARY; SKIN TUMOR; TREATMENT OUTCOME; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BLEOMYCIN; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84996554963     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-4046-y     Document Type: Article

References (40)

1. ten Bokkel Huinink W (1999) Treatment of skin metastases of breast cancer. Cancer Chemother Pharmacol 44(Suppl):S31–S33
2. Moore S (2002) Cutaneous metastatic breast cancer. Clin J Oncol Nurs 6:255–260
3. De Giorgi V, Grazzini M, Alfaioli B, Savarese I, Corciova SA, Guerriero G, Lotti T (2010) Cutaneous manifestations of breast carcinoma. Dermatol Ther 23:581–589
4. Huston TL, Simmons RM (2005) Locally recurrent breast cancer after conservation therapy. Am J Surg 189:229–235
5. Buchanan CL, Dorn PL, Fey J, Giron G, Naik A, Mendez J, Murphy C, Sclafani LM (2006) Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg 203:469–474
6. Jatoi I, Proschan MA (2005) Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol 28:289–294
7. Larkin JO, Collins CG, Aarons S, Tangney M, Whelan M, O’Reily S, Breathnach O, Soden DM, O’Sullivan GC (2007) Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg 245:469–479
8. Gothelf A, Mir LM, Gehl J (2003) Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 29:371–387
9. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72:3694–3700
10. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M (2008) Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 34:232–240
11. Sersa G, Cufer T, Paulin SM, Cemazar M, Snoj M (2012) Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev 38:379–386
12. Neumann E, Kakorin S, Toensing K (1999) Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenergy 48:3–16
13. Heller R, Gilbert R, Jaroszeski MJ (1997) Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. Adv Drug Deliv Rev 26:185–197
14. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C (1991) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27:68–72
15. Mir L (2006) Bases and rationale of the electrochemotherapy. EJC Suppl 4:38–44
16. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, Geertsen PF, Rudolf Z, O’Sullivan GC, Marty M (2006) Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. EJC Suppl 4:14–25
17. http://www.igeamedical.com/sites/default/files/prodotti/cliniporator-performances/files_allegati/cliniporatortechnicalsheet.pdf
18. WHO (1979) Handbook for reporting results of cancer treatment, vol 48. WHO Offset, Geneva, pp 22–27
19. Lund-Nielsen B, Muller K, Adamsen L (2005) Malignant wounds in women with breast cancer: feminine and sexual perspectives. J Clin Nurs 14:56–64
20. Weaver JC (1995) Electroporation theory. Concepts and mechanisms. Methods Mol Biol 55:3–28
21. Neal RE 2nd, Singh R, Hatcher HC, Kock ND, Torti SV, Davalos RV (2010) Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat 123:295–301
22. Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM (2007) Tumor ablation with irreversible electroporation. PLoS ONE 2:e1135
23. Langer R (1990) New methods of drug delivery. Science 249:1527–1533
24. Gehl J, Sorensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T, Mir LM (1999) In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1428:233–240
25. Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J Jr, Schwaab G, Luboinski B, Paoletti C (1991) Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III 313:613–618
26. Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, Savoia P, Bernengo MG (2008) Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 15:2215–2222
27. Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, Vecchiato A, Corti L, Rossi CR, Nitti D (2009) Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol 16:191–199
28. Marty M, Sersa S, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D, Pavlovic I, Paulin-Kosir SM, Cemazar M, Morsli N, Soden DM, Rudolf Z, Robert C, O’Sullivan GC, MIr LM (2006) Electrochemotherapy—an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Supp 4:3–13
29. Skarlatos I, Kyrgias G, Mosa E, Provatopoulou X, Spyrou M, Theodorou K, Lepouras A, Gounaris A, Koukourakis M (2011) Electrochemotherapy in cancer patients: first clinical trial in Greece. In Vivo 25:265–274
30. Campana LG, Valpione S, Mocellin S, Sundararajan R, Granziera E, Sartore L, Chiarion-Sileni V, Rossi CR (2012) Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg 99:821–830
31. Poddevin B, Orlowski S, Belehradek J Jr, Mir LM (1991) Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 42(Suppl):S67–75
32. Kalmykow B, Walker S (2011) Cutaneous metastases in breast cancer. Clin J Oncol Nurs 15:99–101
33. Hussein MR (2010) Skin metastasis: a pathologist’s perspective. J Cutan Pathol 37:e1–20
34. Clemons M, Danson S, Hamilton T, Goss P (2001) Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev 27:67–82
35. Saeed S, Keehn CA, Morgan MB (2004) Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol 31:419–430
36. Nashan D, Meiss F, Braun-Falco M, Reichenberger S (2010) Cutaneous metastases from internal malignancies. Dermatol Ther 23:567–580
37. Braverman AS (2009) Cutaneous metastases from breast cancer. South Med J 102:343–344
38. Clive S, Gardiner J, Leonard RC (1999) Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma. Cancer Chemother Pharmacol 44(Suppl):S29–30
39. Fentiman IS, Matthews PN, Davison OW, Millis RR, Hayward JL (1985) Survival following local skin recurrence after mastectomy. Br J Surg 72:14–16
40. Mali B, Miklavcic D, Campana LG, Cemazar M, Sersa G, Snoj M, Jarm T (2013) Tumor size and effectiveness of electrochemotherapy. Radiol Oncol 47:32–41